Problems with menstruation, painful periods, endometriosis, myomas – gynecological diseases can seriously impair a woman's feeling of well-being and quality of life. The origin of these diseases can lie in hormonal imbalances.
For many years, Bayer has been offering effective hormonal preparations for treating gynecological diseases and will continue to work on the development of innovative drugs in the future with the aim of restoring the quality of life of the women affected.
A high production of male sex hormones (androgens) in women can, for example, lead to acne, hirsutism (male-type body/facial hair), and androgenic alopecia (male-type hair loss). Not only are these disorders troublesome for cosmetic reasons to the women affected, they are also frequently accompanied by disorders of the menstrual cycle or the development of ovarian cysts. Women with high androgen levels also have an increased risk of infertility.
A hormone preparation with the active ingredients cyproterone acetate (CPA) and ethinyl estradiol can be used to treat acne. CPA's anti-androgenic effect is used to reliably treat androgenic phenomena like acne. In addition to the anti-androgenic effect already described, CPA also has a contraceptive effect. No additional hormonal or other contraceptives for contraception therefore need to be used.
Endometriosis and myomas
In research and development, Bayer concentrates on gynecological diseases such as endometriosis and myomas (uterine fibroids), which can seriously impair the quality of life and for which there is no satisfactory drug therapy. A drug for the treatment of endometriosis was launched in the EU in 2010. It is also approved in several countries in Latin America and Asia Pacific.
Advice for patients
Each body reacts differently to medicines. Therefore it is impossible to tell which medicine works best for you. Please consult your physician.